Recombinant Saccharomyces cerevisiae Ferric/cupric reductase transmembrane component 1 (FRE1)

What is the basic structure and function of FRE1?

FRE1 is a transmembrane protein functioning as a ferric/cupric reductase in Saccharomyces cerevisiae (baker's yeast). The mature protein spans amino acids 23-686 of the full sequence and contains multiple transmembrane domains that facilitate its role in metal ion reduction at the cell surface . FRE1 plays a critical role in iron and copper homeostasis by reducing Fe(III) and Cu(II) to their more bioavailable Fe(II) and Cu(I) forms, respectively.

The protein contains characteristic sequence motifs including cysteine-rich regions (visible in the N-terminal portion: TLISTSCISQAALYQFGCSSKSKSCYCKNIN...) that are often associated with metal binding or redox activity . The transmembrane topology is essential for its functional mechanism, allowing electron transfer across the membrane to reduce extracellular metal ions.

For studying FRE1's structure-function relationship, researchers should consider that recombinant versions typically include tags (such as His-tags) that may influence certain biophysical assays but generally preserve catalytic functionality .

How should recombinant FRE1 be stored to maintain optimal activity for experiments?

Proper storage of recombinant FRE1 is critical for maintaining its structural integrity and enzymatic activity. The protein should be stored at -20°C to -80°C for extended storage periods . For working solutions, storage at 4°C is recommended, but only for up to one week to prevent activity loss .

When handling recombinant FRE1, researchers should avoid repeated freeze-thaw cycles as these can significantly decrease protein activity and structural integrity . A methodological approach to minimize freeze-thaw damage includes:

• Aliquoting the protein solution immediately after reconstitution

• Adding glycerol to a final concentration of 5-50% (with 50% being optimal for many applications)

• Using deionized sterile water for reconstitution to a concentration of 0.1-1.0 mg/mL

The storage buffer composition (Tris/PBS-based buffer with 6% Trehalose, pH 8.0) has been optimized to maintain stability during freeze-thaw transitions . This buffer system helps prevent protein aggregation and maintains the native conformation of the transmembrane regions.

What expression systems are most effective for producing functional recombinant FRE1?

The most commonly used and effective expression system for recombinant FRE1 production is Escherichia coli . Despite FRE1 being a eukaryotic transmembrane protein, E. coli expression systems have been successfully employed to produce functional protein when proper folding conditions are established.

For methodological considerations, researchers should note that recombinant FRE1 is typically expressed as the mature protein (amino acids 23-686) rather than the full-length sequence including the signal peptide . This approach improves expression efficiency and proper folding in heterologous systems.

The addition of a histidine tag (either N-terminal His-tag or 10xHis-tagged constructs) facilitates purification using immobilized metal affinity chromatography (IMAC) while generally preserving the functional properties of the protein . When designing expression constructs, researchers should consider that the tag location may affect membrane insertion and topology, with N-terminal tags generally being preferred for this particular protein.

How should researchers design experiments to assess FRE1 reductase activity in vitro?

When designing experiments to assess FRE1 reductase activity, researchers must carefully consider several methodological aspects to ensure reliable and reproducible results. A systematic experimental approach should follow these principles:

• Define the independent variable (substrate concentration, pH, temperature) and dependent variable (reductase activity measured as Fe(III) or Cu(II) reduction)

• Establish appropriate controls, including heat-inactivated enzyme and no-enzyme controls

• Account for potential confounding variables such as spontaneous reduction and metal ion contamination

A typical assay methodology involves:

• Reconstituting the lyophilized protein in an appropriate buffer system

• Creating a reaction mixture containing the metal substrate (Fe(III) or Cu(II) complexes)

• Adding an appropriate electron donor system

• Measuring reduction rates through spectrophotometric methods or colorimetric indicators

What are the key variables to control when using recombinant FRE1 in reduction assays?

When conducting reduction assays with recombinant FRE1, researchers must control several key variables to ensure experimental validity and reproducibility. These variables can be categorized as follows:

Researchers should apply a systematic approach to variable manipulation, changing only one independent variable at a time while maintaining others constant . This allows for clear establishment of cause-effect relationships between experimental conditions and FRE1 activity.

For advanced studies, consider within-subject or between-subject experimental designs depending on whether you're examining the effect of multiple conditions on the same protein preparation or comparing different protein variants under identical conditions .

How can researchers effectively reconstitute lyophilized FRE1 for functional studies?

Effective reconstitution of lyophilized FRE1 is critical for maintaining protein functionality in subsequent experiments. A methodological approach to reconstitution should include:

• Brief centrifugation of the vial prior to opening to ensure all protein content settles at the bottom

• Reconstitution using deionized sterile water to a final concentration of 0.1-1.0 mg/mL

• Gentle mixing by inversion rather than vortexing to prevent protein denaturation

• Addition of glycerol to a final concentration of 5-50% for storage stability

• Immediate aliquoting to prevent repeated freeze-thaw cycles

For membrane proteins like FRE1, consideration should be given to the potential need for detergents or lipid environments to maintain proper folding and functionality. While the product information doesn't explicitly mention detergent requirements, researchers studying transmembrane protein function should evaluate whether addition of mild non-ionic detergents might improve protein stability or activity in their specific experimental system.

The reconstitution process should be validated by assessing protein activity immediately after reconstitution to establish a baseline for subsequent storage condition comparisons and experimental planning.

What approaches can be used to study the metal specificity of FRE1 in different experimental contexts?

Studying the metal specificity of FRE1 requires sophisticated experimental approaches that can distinguish between different metal reduction activities. Researchers can employ several methodological strategies:

• Comparative kinetic analysis using various metal substrates (Fe(III), Cu(II), and other transition metals)

• Competition assays with mixed metal substrates to determine preferential reduction

• Site-directed mutagenesis of potential metal-binding residues, particularly focusing on the cysteine-rich regions (TLISTSCISQAALYQFGCSSKSKSCYCKNIN) in the N-terminal domain

• Spectroscopic approaches (EPR, X-ray absorption) to directly observe metal binding and reduction events

When designing these experiments, researchers should consider:

• The specific hypothesis being tested about metal selectivity

• Appropriate controls to account for spontaneous reduction of metal ions

• The potential influence of the His-tag on metal binding properties

• The need for anaerobic conditions to prevent re-oxidation of reduced metal species

Analysis of the protein sequence reveals multiple potential metal-binding motifs, particularly in the cysteine-rich regions, which may participate differently in the reduction of various metal ions . Advanced researchers can correlate functional data with structural predictions to develop mechanistic models of FRE1's metal discrimination properties.

How can researchers investigate the membrane topology and integration of FRE1?

Investigating the membrane topology and integration of FRE1 requires specialized techniques designed for transmembrane proteins. A comprehensive methodological approach includes:

• Protease accessibility assays to determine exposed versus protected regions of the protein

• Fluorescence-based techniques using site-specific labeling of cysteine residues

• Epitope insertion studies combined with immunofluorescence microscopy

• Computational prediction tools validated with experimental data

The full amino acid sequence of FRE1 (amino acids 23-686) contains multiple hydrophobic regions that likely form transmembrane domains . These domains are essential for the protein's function in reducing extracellular metal ions while utilizing intracellular electron donors.

For experimental work, researchers should consider:

• The influence of the His-tag on membrane insertion and topology

• The possible need for yeast-specific lipids to achieve native conformation

• Differences between recombinant systems (E. coli) and the native yeast environment

A thorough topological analysis would map the orientation of each transmembrane segment and identify regions exposed to either side of the membrane, providing insights into the electron transfer pathway involved in metal reduction.

What techniques can be employed to study FRE1 interactions with other components of yeast iron and copper homeostasis systems?

Studying FRE1's interactions with other components of yeast metal homeostasis systems requires integrative approaches combining molecular, biochemical, and cellular techniques. Advanced researchers should consider these methodological strategies:

• Co-immunoprecipitation studies using the His-tagged FRE1 as bait to identify interaction partners

• Yeast two-hybrid or split-ubiquitin assays optimized for membrane protein interactions

• Proximity labeling approaches (BioID, APEX) to identify neighboring proteins in the cellular context

• Genetic interaction studies using synthetic lethality/sickness screens

When designing interaction studies, researchers should:

• Consider both stable and transient interactions

• Account for the transmembrane nature of FRE1 when selecting appropriate techniques

• Validate interactions using multiple independent methods

• Correlate interaction data with functional outcomes in metal homeostasis

Analysis of the FRE1 sequence (TLISTSCISQAALYQFGCSSKSKSCYCKNIN...) reveals potential interaction motifs, particularly in the N-terminal and C-terminal regions that likely extend into the cytoplasm or extracellular space . These regions may mediate interactions with other components of the iron and copper uptake systems in yeast.

What are common challenges in working with recombinant FRE1 and how can they be addressed?

Working with recombinant FRE1 presents several technical challenges due to its nature as a transmembrane protein. Researchers commonly encounter these issues:

• Protein aggregation during storage or thawing:

  • Methodological solution: Add glycerol (5-50%) to storage buffer and aliquot into single-use volumes

  • Avoid repeated freeze-thaw cycles and store working aliquots at 4°C for up to one week

• Loss of activity during reconstitution:

  • Methodological solution: Reconstitute in appropriate buffer (Tris/PBS-based, pH 8.0) with 6% Trehalose

  • Consider adding mild non-ionic detergents if forming micelles or proteoliposomes

• Difficulty measuring activity in vitro:

  • Methodological solution: Optimize electron donor systems and metal substrate complexes

  • Consider anaerobic conditions to prevent re-oxidation of reduced metal species

• Variability between protein preparations:

  • Methodological solution: Implement rigorous quality control testing including SDS-PAGE analysis (>90% purity)

  • Develop quantitative activity assays to normalize across preparations

Researchers should document troubleshooting steps systematically, testing one variable at a time while maintaining others constant to identify optimal conditions for their specific experimental application .

How can researchers validate that recombinant FRE1 retains native conformation and activity?

• Functional assays:

  • Measure ferric and cupric reductase activities using established spectrophotometric methods

  • Compare kinetic parameters (Km, Vmax) with literature values for native FRE1

• Structural validation:

  • Circular dichroism (CD) spectroscopy to assess secondary structure content

  • Limited proteolysis to examine domain folding and accessibility

  • Thermal stability assays to determine melting temperature

• Comparative analysis:

  • Side-by-side testing with native FRE1 (if available)

  • Complementation studies in fre1 deletion yeast strains

• Activity controls:

  • Include positive controls (known active preparations) and negative controls (heat-inactivated enzyme)

  • Test responsiveness to known inhibitors or activators

For recombinant FRE1 expressed in E. coli, researchers should be particularly attentive to proper folding of the transmembrane domains, which may require specialized expression conditions or post-expression processing . The His-tag, while useful for purification, should be evaluated for its potential impact on protein function through comparative studies with untagged or differently tagged versions when possible .

What analytical methods are most appropriate for assessing FRE1 purity and structural integrity?

A comprehensive analytical approach to assessing FRE1 purity and structural integrity should combine multiple complementary techniques. Researchers should implement:

• Purity assessment:

  • SDS-PAGE with Coomassie or silver staining (should show >90% purity)

  • Size exclusion chromatography to detect aggregates and oligomeric states

  • Western blotting using anti-His antibodies for tagged protein detection

• Structural integrity analysis:

  • Mass spectrometry to confirm protein identity and detect post-translational modifications

  • Circular dichroism spectroscopy to evaluate secondary structure composition

  • Fluorescence spectroscopy to assess tertiary structure through intrinsic tryptophan fluorescence

• Functional correlates:

  • Activity assays as indicators of proper folding

  • Ligand binding assays using known substrates or inhibitors

  • Thermal shift assays to evaluate stability under various conditions

When interpreting analytical data, researchers should consider that transmembrane proteins like FRE1 may exhibit atypical behavior in certain assays due to their hydrophobic nature. For example, apparent molecular weight on SDS-PAGE may differ from calculated values, and standard protein quantification methods may require calibration specific to membrane proteins.

The multi-method approach provides a more complete picture of protein quality than any single technique and helps researchers establish quality control benchmarks for consistent experimental performance.

How might structural studies of FRE1 advance understanding of its catalytic mechanism?

Advanced structural studies of FRE1 would significantly enhance our understanding of its catalytic mechanism and metal specificity. Future research directions should consider:

• Cryo-electron microscopy approaches:

  • Determination of high-resolution structures in different conformational states

  • Visualization of metal binding sites and electron transfer pathways

  • Mapping of transmembrane topology in a lipid environment

• Computational modeling and simulation:

  • Molecular dynamics simulations to understand conformational dynamics

  • Quantum mechanical calculations of the electron transfer process

  • Docking studies with different metal substrates to explain specificity

• Structure-guided mutagenesis:

  • Systematic alteration of potential metal-coordinating residues

  • Modification of transmembrane domains to understand membrane integration

  • Engineering of variants with altered metal specificity

The complete amino acid sequence of FRE1 (TLISTSCISQAALYQFGCSSKSKSCYCKNIN...) contains numerous conserved motifs that likely play crucial roles in catalysis. Detailed structural information would allow researchers to connect sequence features with specific functional roles and potentially design improved variants for biotechnological applications.

What methodological advances would help better understand FRE1's role in cellular metal homeostasis?

Understanding FRE1's role in cellular metal homeostasis requires innovative methodological approaches that bridge molecular mechanisms with cellular physiology. Future methodological directions include:

• Advanced imaging techniques:

  • Super-resolution microscopy to visualize FRE1 distribution and dynamics

  • Correlative light and electron microscopy to connect function with ultrastructure

  • Live-cell metal sensors to monitor reduction activity in real-time

• Systems biology approaches:

  • Multi-omics integration (transcriptomics, proteomics, metallomics)

  • Network analysis of metal homeostasis pathways

  • Mathematical modeling of metal reduction and transport dynamics

• Genetic engineering advances:

  • CRISPR-Cas9 modification of endogenous FRE1

  • Optogenetic control of FRE1 expression or activity

  • Synthetic biology approaches to reconstitute metal homeostasis systems

• Translational approaches:

  • Development of FRE1-based biosensors for environmental metal detection

  • Exploration of FRE1 homologs in pathogenic fungi as potential drug targets

These methodological advances would help researchers move beyond in vitro characterization of recombinant FRE1 to understand its dynamic behavior in living cells and its coordination with other components of metal homeostasis systems.

How can recombinant FRE1 be utilized to develop novel biotechnological applications?

Recombinant FRE1 presents numerous opportunities for biotechnological innovation based on its metal reduction capabilities. Researchers exploring these applications should consider:

• Environmental remediation technologies:

  • Immobilized FRE1 systems for heavy metal bioremediation

  • Engineered microorganisms with enhanced FRE1 expression for contaminated soil treatment

  • Coupled enzyme systems for complete metal transformation processes

• Biosensor development:

  • FRE1-based electrochemical sensors for metal ion detection

  • Whole-cell biosensors using FRE1 promoter-reporter fusions

  • Point-of-use devices for water quality monitoring

• Biomaterials production:

  • Controlled metal nanoparticle synthesis through enzymatic reduction

  • Creation of novel metal-protein hybrid materials

  • Surface functionalization using immobilized FRE1

• Industrial biotechnology:

  • Enhanced microbial fermentation through improved metal bioavailability

  • Bioprocessing applications requiring controlled redox environments

  • Enzymatic alternatives to chemical reducing agents

When developing these applications, researchers should leverage the detailed molecular understanding of recombinant FRE1, including its expression and reconstitution protocols , while considering how protein engineering might enhance stability, activity, or specificity for specific biotechnological contexts.